Makale detayı · 2021
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
Dergi
LANCETISSN 0140-6736
ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
YÖKSİS
OpenAlex
Açık erişim · bronze
SJR Q1
JCR Q1
Atıf 934
Üst %1
Yüzdelik 99.9%
FWCI 54.91
- Yıl
- 2021
- Tür
- article
Veri kaynağı ayrımı
- YÖKSİS YÖKSİS makale kaydı
- YÖKSİS dergi adı LANCET
- Katalog eşleşmesi (ISSN) The Lancet
- OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
934 atıf
OpenAlex cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 251 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- Evaluation of antibody response after COVID\u201019 vaccination of healthcare workers 2022
- Early experience of COVID‐19 vaccine‐related adverse events among adolescents and young adults with rheumatic diseases: A single‐center study 2022
- Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study 2022
- An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in Turkey 2022
- An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in Turkey. 2022
- COVID-19: vaccination vs. hospitalization 2022
- COVID-19: vaccination vs. hospitalization 2022
- COVID-19: vaccination vs. hospitalization 2022
- COVID‑19: vaccination vs. hospitalization 2022
- COVID-19: vaccination vs. hospitalization 2022